I attended the meeting but left after two hours and suspect it...

I attended the meeting but left after two hours and suspect it will have run a while longer. Had a mostly positive vibe.
Very briefly, their aim is to relist by the end of the calendar year, a process that will include an IPO raising of up to six million dollars. Prospectus is in draft mode. More dilution coming.
On the positive side they presented a large number of products and partnership, all with rosy future predictions. Encouragingly they actually expect to run a positive sales v expenses for FY 16, improvement to come.
Keen to also push the position the company is in regarding patents granted over the past five years, focusing on the five granted in the US as very positive.
Obviously acknowledged they have a lot of ground to claw back with investors, especially in trying to sell the IPO.
Company name change to Prenolica is official, website prenolica.com is up and running. The presentation will hopefully be up there soon.